Staff Profile: Jane C. Atkinson

Jane Atkinson
Jane C. Atkinson, D.D.S.

Director, Trial Innovation Network

Division of Clinical Innovation

National Center for Advancing Translational Sciences

National Institutes of Health

Email Jane C. Atkinson

Biography

Jane Atkinson is the director of the Trial Innovation Network in the NCATS Division of Clinical Innovation. The Trial Innovation Network is a collaborative initiative within NCATS’ Clinical and Translational Science Awards (CTSA) Program and is composed of three key organizational partners: the Trial Innovation Centers, the Recruitment Innovation Center and the CTSA Program hubs. Prior to joining NCATS in December 2017, Atkinson held several positions at the National Institute of Dental and Craniofacial Research (NIDCR). She started as a clinical research fellow in the NIDCR Intramural Program, eventually becoming an associate or principal investigator for several studies of individuals with salivary gland dysfunction or oral mucosal diseases. She was also a staff dentist at the National Institutes of Health (NIH) Clinical Center. From 2000 to 2004, Atkinson served as professor and assistant dean for clinical affairs at the University of Maryland’s Baltimore College of Dental Surgery. In 2004, she returned to the NIDCR Intramural Program as deputy clinical director and moved to the Division of Extramural Research to serve as the director of clinical research from 2008 to 2017.

Atkinson has served on several trans-NIH committees, including the NIH Clinical Trials Stewardship Working Group, the NIH Inclusion Governance Committee and the All of Us NIH Liaisons Coordination Team.

Atkinson received her D.D.S. from the University of Missouri-Kansas City.

Research Topics

Atkinson’s research interests focus on improving the quality of clinical trials, Sjögren’s syndrome, the oral health of cancer patients and the oral manifestations of rare genetic diseases.

Selected Publications

  1. 2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts.
  2. Salivary gland involvement in chronic graft-versus-host disease: prevalence, clinical significance, and recommendations for evaluation.
  3. Mendelian forms of periodontitis.
  4. Identification of parotid salivary biomarkers in Sjogren's syndrome by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry and two-dimensional difference gel electrophoresis.
  5. Randomized, double-blind, placebo-controlled phase IIb trial of the cyclooxygenase inhibitor ketorolac as an oral rinse in oropharyngeal leukoplakia.